{"url_path":"/sec/gri/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1824293/0001824293-26-000044-index.html","accession_number":"0001824293-26-000044","cik":"0001824293","ticker":"GRI","issuer_name":"GRI Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1824293/0001824293-26-000044-index.html","primary_entity_key":"0001824293","primary_entity_name":"GRI Bio, Inc."},"word_count":313,"has_tables":true,"body_markdown":"Item 6. Exhibits.\n\nExhibit\nNumberDescriptionFiled HerewithFormIncorporated by Reference File No. Date Filed\n\n3.1\n[Amended and Restated Certificate of Incorporation, as amended.](https://www.sec.gov/Archives/edgar/data/1824293/000182429326000033/gri-202510xk_ex31.htm)\n10-K001-400341/30/2026\n\n3.2\n[Amended and Restated Bylaws.](https://www.sec.gov/Archives/edgar/data/1824293/000182429323000129/gribioinc-amendedandrestat.htm)\n8-K/A001-400345/26/2023\n\n10.1\n[Amendment No. 1 to At The Market Offering Agreement, dated as of January 29, 2026, between GRI Bio, Inc. and H.C. Wainwright & Co., LLC.](https://www.sec.gov/Archives/edgar/data/1824293/000182429326000030/gri-atmx8xkex101amendmentn.htm)\n8-K001-400341/30/2026\n\n31.1\n[Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex311_ceo302cert33126.htm)\nX\n\n31.2\n[Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex312_cfo302cert33126.htm)\nX\n\n32.1*\n[Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex321_ceosection906cert331.htm)\nX\n\n32.2*\n[Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex322_cfosection906cert331.htm)\nX\n\n101.INSiXBRL Instance Document\n\n101.SCHiXBRL Taxonomy Extension Schema Document\n\n101.CALiXBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEFiXBRL Taxonomy Extension Definition Linkbase Document\n\n101.LABiXBRL Taxonomy Extension Label Linkbase Document\n\n101.PREiXBRL Taxonomy Extension Presentation Linkbase Document\n\n104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)\n\n____________________________________\n\nUnless otherwise indicated, exhibits are filed herewith.\n\n*This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, except to the extent specifically incorporated by reference into such filing.\n\n26\n\n[Table of Contents](#i50f83595bfc24cd3be8c8dbcbb826d3e_7)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nGRI BIO, INC.\n\nDate: May 13, 2026By:/s/ Leanne M. Kelly\n\nName: Leanne M. Kelly\n\nTitle: Chief Financial Officer\n\n(Principal Financial and Accounting Officer)\n\n27"}